Rentabilitas dodolan miturut bathi resik Nautilus Bio (NAUT)

NAUT (nautilus.bio) - tandha merek perusahaan

Nautilus Biotechnology (NAUT) is developing an advanced proteome study system for the synthesis of modern pharmaceuticals. The historical sales margin level displayed by the GURU.Markets portal confirms this strategy, with the current level sitting around -13816.80. Business efficiency is based on proprietary chips for low-cost DNA screening and modernized optical systems in laboratories.

nautilus.bio (NAUT) - Margin resik saka 04.07.2022 nganti 19.11.2026

Nautilus Bio (NAUT) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Ringkesan analisis perusahaan:Nautilus Biotechnology
Barang unggulan nautilus.bio

Sales margin determines the share of net profit in every dollar of revenue, measuring the efficiency of converting income into final capital. The current value of -13816.80 reflects the ability of Nautilus Biotechnology (NAUT) to retain profit amidst fierce competition with DNA sequencing behemoths. By analyzing the company's sales margin history, an investor can discern the real cost of implementing proteomic tools in laboratories. A compression of this metric signals a loss of competitive advantage, while the stability of the metric confirms the resilience of the business model.

Analisis perusahaan pesaing

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX